P

Inventor

SAFINA BRIAN

US38 patents
⚠️ This page may combine multiple inventors who share the name “SAFINA BRIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENENTECH INC

21 patents
US8933236B2Jan 13, 2015

N-substituted benzamides and methods of use thereof

GENENTECH INC50 citations97
US8952169B2Feb 10, 2015

N-substituted benzamides and methods of use thereof

GENENTECH INC25 citations92
US9771376B2Sep 26, 2017

N-substituted benzamides and methods of use thereof

GENENTECH INC7 citations84
US10005724B2Jun 26, 2018

Therapeutic compounds and methods of use thereof

GENENTECH INC6 citations83
US9694002B2Jul 4, 2017

Substituted benzamides and methods of use thereof

GENENTECH INC11 citations83
US9546164B2Jan 17, 2017

Substituted benzamides and methods of use thereof

GENENTECH INC13 citations83
US8563540B2Oct 22, 2013

Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use

GENENTECH INC6 citations83
US10533058B2Jan 14, 2020

Peptidomimetic compounds and antibody-drug conjugates thereof

GENENTECH INC2 citations72
US10125098B2Nov 13, 2018

Therapeutic compounds and methods of use thereof

GENENTECH INC2 citations72
US9550775B2Jan 24, 2017

Substituted triazolopyridines and methods of use thereof

GENENTECH INC7 citations72
US10124069B2Nov 13, 2018

Peptidomimetic compounds and antibody-drug conjugates thereof

GENENTECH INC3 citations71
US11692043B2Jul 4, 2023

Peptidomimetic compounds and antibody-drug conjugates thereof

GENENTECH INC0 citations61
US10787446B2Sep 29, 2020

Therapeutic compounds and methods of use thereof

GENENTECH INC1 citations59
US10071957B2Sep 11, 2018

N-substituted benzamides and methods of use thereof

GENENTECH INC1 citations52
US10632210B2Apr 28, 2020

Peptidomimetic compounds and antibody-drug conjugates thereof

GENENTECH INC0 citations51
US10179767B2Jan 15, 2019

Substituted benzamides and methods of use thereof

GENENTECH INC0 citations51
US9999681B2Jun 19, 2018

Peptidomimetic compounds and antibody-drug conjugates thereof

GENENTECH INC1 citations51
US10711004B2Jul 14, 2020

Oxadiazole transient receptor potential channel inhibitors

GENENTECH INC0 citations37
US10544215B2Jan 28, 2020

1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment

GENENTECH INC0 citations37
US10442836B2Oct 15, 2019

1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment

GENENTECH INC0 citations37
US7749994B2Jul 6, 2010

Pentacyclic kinase inhibitors

GENENTECH INC0 citations37

CASTANEDO GEORGETTE

4 patents

MITCHELL IAN S

3 patents

BOLT BIOTHERAPEUTICS INC

3 patents

ARRAY BIOPHARMA INC

2 patents

HEALD ROBERT

1 patent

LI JUN

1 patent

BENCSIK JOSEF

1 patent

BENCSIK JOSEF R

1 patent

HEFFRON TIMOTHY

1 patent